2 results
DEF 14A
TSBX
Turnstone Biologics Corp.
22 Apr 24
Definitive proxy
4:28pm
The Board of Directors has three committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The following table provides membership and meeting information for fiscal 2023 for each of the committees of the Board of Directors:
Name | Audit | Compensation | Nominating and Corporate Governance | |||||||
Jerel Davis, Ph.D. | X | X* | ||||||||
Robert Gould, Ph.D. | X | X | ||||||||
Rishi Gupta, J.D. | X | X* | ||||||||
Patrick Machado(1) | X* | X | ||||||||
Kanya Rajangam, M.D., Ph.D. | X | |||||||||
Total meetings in fiscal 2023 | 3 | 5 | — |
DEF 14A
TSBX
Turnstone Biologics Corp.
22 Apr 24
Definitive proxy
4:28pm
The following table represents aggregate fees billed to the Company for the fiscal years ended December 31, 2023 and December 31, 2022, by Ernst & Young LLP, the Company’s principal accountant. All fees described below were pre-approved by the Audit Committee.
Fiscal Year Ended | ||||||||
2023 | 2022 | |||||||
Audit Fees(1) | $ | 1,508,407 | $ | 800,486 | ||||
Audit-related Fees | $ | — | $ | — | ||||
Tax Fees | $ | — | $ | — | ||||
All Other Fees | $ | — | $ | — | ||||
Total Fees | $ | 1,508,407 | $ | 800,486 |
- Prev
- 1
- Next